Doctor profile · Federal record
Dr. ASAD AL-RAWASHDEH, MD
Nephrology Physician (CMS: INTERNAL MEDICINE) · Nephrology Physician · Nephrology Physician · JOPLIN, MO
- NPI 1619421963
- Accepts Medicare
- MIPS 53.4 / 100 · 2023
- 20 yrs in practice
- Licensed in 3 states
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
522 W 32ND ST STE 1
JOPLIN, MO 648042533
(174) 782-5000
fax (417) 782-2945 - Mailing address
-
522 W 32ND ST, STE 1
JOPLIN, MO 648042533
Credentials & registration
- NPI registered
- August 2016 — 10 yrs on file
- Profile last updated
- June 16, 2022
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 207RN0300X — NUCC code
- State licenses (3)
- Kansas #04-45616 · Missouri #2021044826 · Texas #BP10056172
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1619421963. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,459
Distinct HCPCS
6
Medicare allowed
$154,675
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 557 | 269 | $118 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 428 | 114 | $74 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 180 | 65 | $112 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 123 | 123 | $154 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 122 | 108 | $123 | |
90935 |
Hemodialysis procedure with physician evaluation | 49 | 20 | $67 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 132. This provider delivers 11× the peer median.Open Payments
Industry payments received
All-time total
$471
Transactions
26
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $93.04 | |
| Travere Therapeutics, Inc. | 6 | $74.62 | |
| CALLIDITAS THERAPEUTICS US INC. | 3 | $63.55 | |
| Amgen Inc. | 2 | $50.55 | |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35.05 | |
| Mallinckrodt Hospital Products Inc. | 1 | $22.00 | |
| Fresenius USA Marketing, Inc. | 1 | $20.92 | |
| AKEBIA THERAPEUTICS INC | 1 | $19.50 | |
| GlaxoSmithKline, LLC. | 1 | $17.40 | |
| Novo Nordisk Inc | 1 | $16.47 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15.95 | |
| AstraZeneca Pharmaceuticals LP | 1 | $14.00 | |
| Vifor Pharma, Inc. | 1 | $14.00 | |
| OPKO Pharmaceuticals, LLC | 1 | $13.90 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,367
Patients
344
Total drug cost
$39,637
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Losartan Potassium | Generic | 205 | 49 | $1,577 |
| Tamsulosin Hcl | Generic | 181 | 39 | $2,382 |
| Hydrochlorothiazide | Generic | 169 | 38 | $571 |
| Allopurinol | Generic | 157 | 40 | $1,128 |
| Lisinopril | Generic | 118 | 41 | $528 |
| Amlodipine Besylate | Generic | 101 | 37 | $607 |
| Furosemide | Generic | 88 | 27 | $329 |
| Hydralazine Hcl | Generic | 62 | 22 | $1,028 |
| Atenolol | Generic | 52 | 0 | $225 |
| Finasteride | Generic | 46 | 12 | $590 |